MustGrow Biologics Corp.
MGRO.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -27.71% | -49.02% | 1,300.38% | -4.07% | -9.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.71% | -49.02% | 1,300.38% | -4.07% | -9.03% |
| Cost of Revenue | 172.53% | 486.05% | 561.77% | 418.66% | 198.20% |
| Gross Profit | 5,603.31% | -827.39% | -269.18% | -102.56% | -100.46% |
| SG&A Expenses | 18.66% | 13.13% | 19.89% | 9.54% | 2.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.10% | 46.46% | 45.75% | 27.64% | 8.07% |
| Operating Income | 11.22% | -13.63% | -15.45% | -2,811.21% | -6,459.52% |
| Income Before Tax | 3.42% | -21.97% | -37.42% | -2,271.69% | -1,017.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.42% | -21.97% | -37.42% | -2,271.69% | -1,017.60% |
| Earnings from Discontinued Operations | -40.03% | -125.54% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.22% | -26.98% | -45.72% | -2,436.37% | -1,106.26% |
| EBIT | 11.22% | -13.63% | -15.45% | -2,811.21% | -6,459.52% |
| EBITDA | -133.87% | -442.94% | -- | -- | -- |
| EPS Basic | 10.13% | -15.42% | -37.63% | -3,822.73% | -1,178.69% |
| Normalized Basic EPS | 24.39% | 0.66% | -16.44% | -3,500.00% | -1,056.41% |
| EPS Diluted | 10.13% | -15.42% | -37.63% | -3,822.73% | -1,178.69% |
| Normalized Diluted EPS | 24.39% | 0.66% | -16.44% | -3,500.00% | -1,056.41% |
| Average Basic Shares Outstanding | 15.66% | 10.25% | 5.16% | 2.30% | 1.68% |
| Average Diluted Shares Outstanding | 15.66% | 10.25% | 5.16% | 2.30% | 1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |